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Abstract
Glycoprotein C (gC) of pseudorabies virus, a swine herpesvirus, initiates virus attachment by binding to heparan sulfate (HS) linked to
proteoglycans (HSPGs) on the cell surface. This interaction facilitates a required step in virus entry, the binding to a non-HS coreceptor,
likely by another viral glycoprotein, gD. We demonstrate that gC has an even more direct role in virus entry than simply promoting adhesion
strengthening. A porcine cell line expressing gC trans-complemented the penetration, but not attachment, defect of gC null mutants. In
addition, gC promoted the colocalization of cell surface HSPGs and the actin cytoskeleton, suggesting a role for filamentous actin in virus
entry. This was supported by results showing that both the engagement of a non-HS coreceptor and entry events subsequent to coreceptor
binding were impaired if cells were first treated with an actin depolymerizing agent, cytochalasin D. Our results suggest a model in which
gC-HS interactions promote not only virus attachment but also virus entry by usurping the normal properties of HSPGs.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Most adherent cells express several different heparan
sulfate (HS) proteoglycans (HSPGs) on their surface. Mem-
bers of the two major families, the membrane-spanning
syndecans and the glycosylphosphoinositide-linked glypi-
cans, bind extracellular ligands such as growth factors
through their HS moieties and serve as coreceptors in mod-
ulating ligand activity (Bernfield et al., 1999). The role of
HSPGs as coreceptors varies, ranging from altering ligand
concentration or conformation to leading to receptor oli-
gomerization. Syndecans indirectly associate with the actin
cytoskeleton upon ligand binding and this association can
lead to specific activities. For example, syndecan-1 sorts to
the basolateral membrane of epithelial cells and appears
necessary for cell shape maintenance while syndecan-4 lo-
calizes at adherens junctions and functions in the formation
of focal adhesions (Rapraeger et al., 1986; Woods and
Couchman, 1994).
HSPGs also serve as coreceptors for a number of patho-
gens, including the herpesviruses (Rostand and Esko, 1997).
Among alphaherpesviruses, glycoprotein C (gC) is princi-
pally involved in the initial attachment to host cells through
an interaction with cell surface HS (Spear, 1993). For the
swine herpesvirus, pseudorabies virus (PRV), gC is the only
envelope component that binds HS, and it has been shown
that gC null mutants, while viable, can be readily removed
from cell surfaces by washing monolayers with phosphate-
buffered saline (PBS) shortly after infection (Flynn and
Ryan, 1996; Karger et al., 1995). The HS-binding domain of
PRV gC was mapped to the amino-terminal one-third of the
protein and was found to consist of three discrete regions of
positively-charged amino acids that can function indepen-
dently to mediate virus attachment (Flynn and Ryan, 1996).
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More recently, the HSPGs that are bound by PRV gC were
resolved from two cell lines, and it was shown that some of
them are likely to be syndecans (Rue and Ryan, 2002).
The binding of gC to cell surface HS is only the first step
in a series of events involving four essential viral glycop-
roteins (gB, gD, and the gH-gL complex) that ultimately
leads to the pH-independent fusion of the viral envelope and
the plasma membrane of the target cell (Klupp et al., 2000;
Turner et al., 1998). After initial attachment, virions engage
a non-HS coreceptor, most likely through gD. Several re-
ceptors for various gD homologs have been identified, and
of these, PRV gD has been shown to bind nectin-1 (also
referred to as HveC), nectin-2 (HveB), and CD155, the
poliovirus receptor (Spear et al., 2000). Nectin-1 is linked
to the actin cytoskeleton through afadin and localizes to
adherens junctions much like syndecan-4 where it is an
adhesion molecule (Takahashi et al., 1999). Recent work
has shown that nectin-1 must associate with afadin to
promote the cell-to-cell spread of herpes simplex virus type
1 (HSV-1), but that entry of HSV-1 through nectin-1
binding is independent of afadin association (Sakisaka et al.,
2001). Far less is known about the interactions of gB and
gH-gL with target cell membranes, but it is conceivable that
the multivalent nature of the herpesvirus envelope is suffi-
cient to bring all necessary components, both viral and
cellular, together to mediate virus entry.
In the absence of gC-mediated binding to HS, PRV
attachment to a non-HS receptor is delayed (Karger and
Mettenleiter, 1993). This observation is consistent with the
idea that the chief role of gC is to facilitate gD binding to a
non-HS coreceptor through adhesion strengthening. But it
has also been reported that PRV gC mutants are defective in
virus penetration as well (Mettenleiter, 1989). We have
addressed the role of gC in virus entry by experimentally
separating the attachment and penetration steps. We found
that gC can fully complement the penetration defect of a gC
mutant in trans as a resident of the target cell membrane,
while at the same time providing no assistance in virus
attachment. In addition, we found that efficient virus pene-
tration of a porcine kidney cell line utilized filamentous
actin, and that bound soluble gC appeared to induce the
colocalization of HSPGs with the actin cytoskeleton. There-
fore, gC may promote efficient PRV entry by usurping the
normal cellular properties of HSPGs rather than simply
using them to adhere to the cell surface.
Results
A PRV gC mutant remains defective for penetration after
binding a non-HS coreceptor
Previous studies have shown that PRV mutants lacking
functional gC do not attach to HS and enter cells with
decreased efficiency (Flynn et al., 1993; Mettenleiter, 1989;
Mettenleiter et al., 1990). This is demonstrated in Fig. 1 for
PRV583, an HS-attachment defective strain whose gC con-
tains amino acid substitutions in each of the three HBDs that
collectively constitute the HS-receptor binding domain
(Flynn and Ryan, 1996). Greater than 90% of the input
plaque-forming units (PFU) of PRV583 were removed by
washing monolayers with PBS after a 1 h incubation at
37°C (Fig. 1A), and fewer than 5% had penetrated the cells
during this time in a standard penetration assay (Fig. 1B). In
contrast, three-fourths of wild-type PFU were resistant to
PBS washes (Fig. 1A), and more than half had penetrated
cells after 1 h at 37°C (Fig. 1B).
Results obtained with PRV583 here and elsewhere
(Flynn and Ryan, 1996) confirm that gC’s major role in
infection is to initiate virus attachment, and therefore effec-
tively to concentrate virions on the cell surface. In addition,
an absence of gC-HS interactions can indirectly reduce
penetration efficiency by impairing virus engagement of a
non-HS coreceptor, a necessary prelude to entry (Peeters et
al., 1992; Rauh and Mettenleiter, 1991). Consequently, if a
more direct role for gC in penetration alone is to be deter-
mined, then gC-mediated attachment and penetration must
be experimentally separated. One way of doing this is to
ensure that all virions are bound to non-HS coreceptors
prior to establishing conditions that permit virus entry. Un-
der these circumstances, any differences between wild-type
and gC mutant virus entry can be attributed directly to
penetration but not to initial gC-HS attachment. These pa-
rameters were accomplished by inoculating PK15 cell
monolayers with wild type or PRV583 at 4°C; this temper-
ature allowed virions to bind non-HS coreceptors, but pre-
vented fusion of the cell membrane and virus envelope.
After 2 h, the inocula were removed, and monolayers were
washed twice with cold medium containing 5 g/ml of
heparin. This treatment has been shown to remove 95% or
more of the PFU that are attached solely to HS or are
Fig. 1. Attachment and penetration profiles of PRV-Be and PRV583 on
PK15 cells. PRV-Be (solid bars) and PRV583 (open bars) were used in
attachment (A), standard 37°C penetration (B), and combined heparin
elution/penetration (C) assays on PK15 cells as described and referenced in
Materials and Methods. In each assay, the average number of plaques on
treated monolayers is expressed as a percentage of the average number of
plaques on control monolayers. Each bar represents the mean of at least
two independent experiments, and the error bars show the standard errors.
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non-specifically bound to cells (Flynn and Ryan, 1996).
Therefore, only virions bound to non-HS coreceptors should
have remained on the heparin-washed monolayers. Because
of this, approximately ten-fold more PFU of PRV583 than
wild type were added to cells to obtain comparable numbers
of bound virions after the wash step. The monolayers were
then subjected to a penetration assay using warm medium to
overlay the heparin-washed cells. The results of this pene-
tration assay are shown in Fig. 1C.
When compared to heparin-washed controls that were
not treated with citrate buffer, nearly 75% of the bound
wild-type PFU had gained resistance to citrate inactivation
by 1 h. This represented an increased efficiency when com-
pared to penetration measured in a standard assay in which
virions were not allowed to first reach non-HS coreceptors
(Fig. 1B). In contrast, only 25% of bound PRV583 virions
had entered cells within 1 h, as judged by comparison to
their own heparin-washed, non-citrate-treated controls (Fig.
1C). Thus, PRV583 still exhibited three-fold lower penetra-
tion than wild type at 1 h, and overall, maintained a simi-
larly poor level of penetration when compared to the results
shown in Fig. 1B. Therefore, promoting the binding of
PRV583 virions to non-HS coreceptors did not restore wild-
type penetration, suggesting that wild-type gC is beneficial
for downstream events in entry. Using strains completely
lacking gC in the virus envelope, similar results have been
obtained by us and others (data not shown; Mettenleiter,
1989).
gC expressed in the target cell complements the
penetration, but not attachment, defect of gC mutants
The role of gC in virus penetration was experimentally
separated from its role in attachment in a second way. We
generated PK15-derived cells (gC-9 cells) that express wild-
type gC on their surface (see Materials and Methods). By
using gC-9 cells to measure the penetration of PRV583
(propagated on PK15 cells), we provided wild-type gC in
trans, where it could bind cell surface HS, but was not a
component of the virus envelope. Thus, the cellularly-ex-
pressed wild-type gC was potentially in a position to pro-
mote virus penetration without facilitating virus attachment
and progression to a non-HS coreceptor. In fact, the levels
of wild-type gC expressed in gC-9 cells were not sufficient
to complement the attachment defect of a gC null mutant
when the mutant virus was first propagated on gC-9 cells
prior to infection of PK15 cells (data not shown).
The experiments depicted in Fig. 1 were repeated on
gC-9 cells using virus lysates prepared on PK15 cells. Un-
like their parental cells, gC-9 cells were spindle-shaped and
less adherent, and did not yield uniformly confluent mono-
layers. These properties made plaques difficult to identify,
and consequently, infectious centers assays were performed
when using these cells (see Materials and Methods). Wild
type exhibited no significant differences in its attachment
and penetration profiles after 60 min on gC-9 cells (Fig. 2)
compared to PK15 cells. The attachment and standard pen-
etration profiles of PRV583 at 37°C were somewhat im-
proved on gC-9 cells than on PK15 cells (compare Fig. 2A
and B with Fig. 1A and B). However, this was not due to
increased initial attachment to gC-9 cells. When an attach-
ment assay was performed at 4°C and followed by an
infectious centers assay, less than 5% of PRV583 virions
attached to gC-9 cells (data not shown). Instead, the appar-
ent improvement in attachment was the result of increased
virus penetration on gC-9 cells since both events occurred
under the conditions used to generate the results shown in
Fig. 2A. This was confirmed when PRV583 virions were
first allowed to bind non-HS coreceptors (Fig. 2C). Under
these conditions, wild-type penetration efficiency was ap-
parently restored to PRV583 virions, as the percentage of
bound PFU that penetrated was the same for both wild type
and PRV583. This was in contrast to the three-fold differ-
ence observed under similar conditions on PK15 cells (Fig.
1C). Notably, we did not observe an increase in the overall
efficiency of plating (eop) of wild type or PRV583 on gC-9
cells compared to PK15 cells (data not shown). These re-
sults suggested that gC, when expressed in target cells, fully
complemented the penetration, but not attachment, defect of
PRV583. Consequently, the entry defect observed for
PRV583 on gC-9 cells in a standard penetration assay per-
formed at 37°C (Fig. 2B) was due solely to poor attachment
and not a defect in penetration per se.
The full extent of complementation on gC-9 cells was
revealed by performing a time course experiment using the
combined heparin elution/penetration format (see Materials
and Methods). To demonstrate that the complemented phe-
notype was not limited to PRV583 virions, we used strain
PRV523 as our attachment defective strain. PRV523 en-
codes a complete deletion of the HS-binding domain within
Fig. 2. Attachment and penetration profiles of PRV-Be and PRV583 on
gC-9 cells. PRV-Be (solid bars) and PRV583 (open bars) were used in
attachment (A), standard 37°C penetration (B), and combined heparin
elution/penetration (C) assays on gC-9 cells as described and referenced in
Materials and Methods. In each assay, the average number of plaques on
treated monolayers is expressed as a percentage of the average number of
plaques on control monolayers. Each bar represents the mean of at least
two independent experiments, and the error bars show the standard errors.
14 C.A. Rue, P. Ryan / Virology 307 (2003) 12–21
gC (Flynn et al., 1993). Similar to PRV583, PRV523 pen-
etrated PK15 cells poorly, with only about 20% of the input
virions having penetrated by 2 h (Fig. 3A). However, on
gC-9 cells, both PRV523 and wild type exhibited remark-
ably fast penetration rates, with more than 80% of the input
virions resistant to citrate inactivation by 30 min. In fact, the
kinetic analysis made it apparent that even wild-type virions
benefited from the expression of gC on target cells.
A second cell line expressing wild-type gC (gC-3 cells)
was used to confirm gC’s role in the trans-complementation
observed in gC-9 cells. In addition, we isolated a cell line
expressing the gC allele of PRV583 (gC-583 cells) to de-
termine if gC’s ability to bind HSPGs was necessary for
complementation. Figs. 3B and 3C show the results of
experiments using these cell lines in combined heparin
elution/penetration assays. On both cell lines, approxi-
mately 70% of bound wild-type virions had penetrated by
1 h, similar to results obtained on PK15 and gC-9 cells. In
contrast, PRV583 efficiently penetrated gC-3 cells, but not
gC-583 cells, in this assay, confirming a role for wild-type
gC in cell-mediated complementation. However, the gC-
583 cells did appear to support better penetration compared
to parental PK15 cells under these conditions, perhaps sug-
gesting that gC could partially facilitate virus penetration in
the absence of HSPG binding. Collectively, the results de-
picted in Figs. 2 and 3 provided direct evidence that gC has
a role in penetration apart from initiating virus attachment to
cells. It was possible that the cellularly-expressed gC was
facilitating virus entry through its interactions with host
cell, and not viral, components. Accordingly, we next fo-
cused on cellular aspects of gC-HS interactions.
Wild-type gC preferentially binds to PK15 cells over actin
filaments
Recently, we have resolved several HSPGs that bind to
gC affinity columns, and which presumably can serve as
cellular receptors for gC (Rue and Ryan, 2002). HSPGs
have been shown to redistribute over the underlying actin
cytoskeleton upon ligand-induced clustering (Martinho et
al., 1996); accordingly, we looked at gC’s binding sites on
the surface of PK15 cells relative to the actin filaments
beneath. A soluble form of gC fused to a cellulose-binding
domain (gC-CBD) was incubated with fixed or unfixed
PK15 cells for 30 min at 37°C. Bound gC-CBD hybrids and
actin filaments were detected by immunofluorescence as
described in Materials and Methods. Some coincidence of
gC-CBD hybrids and actin filaments was observed on fixed
cells (Fig. 4A-C), suggesting that some HSPGs were local-
ized near actin filaments prior to gC-CBD addition. How-
ever, when bound to unfixed cells (Fig. 4D–F), gC-CBD
hybrids colocalized with actin filaments more extensively,
suggesting that HSPGs were induced to align over actin
filaments upon binding gC-CBD proteins. A similar pattern
was observed on gC-9 cells and on PK15 cells infected with
wild-type virus (data not shown). Thus, consistent with
other HS-binding proteins, gC may enlist the actin cytoskel-
eton in promoting virus attachment and/or penetration.
PRV entry is impaired in the presence of cytochalasin D
If the actin cytoskeleton plays a role in the early events
of PRV infection, then dissolution of actin filaments during
infection should impair virus penetration. Standard penetra-
tion assays were therefore performed in the absence or
presence of cytochalasin D (cyto D), an actin-depolymeriz-
ing agent. PK15 cell monolayers were either left untreated
or treated with cyto D prior to inoculation with wild-type
virus; treated monolayers were inoculated with virus dilu-
tions also containing cyto D. After 1 h at 37°C in the
absence of cyto D, 56% of wild-type PFU penetrated PK15
Fig. 3. (A) Penetration kinetics of wild type and a gC mutant. PRV-Be
(solid symbols) or PRV523 (open symbols) was used to infect PK15
(squares) or gC-9 (circles) cells using the combined heparin elution/pene-
tration assay as described in Materials and Methods. For each time point,
the average number of plaques on treated monolayers is expressed as a
percentage of the average number of plaques on control monolayers. The
results shown are the averages of two independent experiments. (B and C)
Combined heparin elution/penetration profiles of wild type and PRV583 on
gC-3 and gC-583 cells. PRV-Be (solid bars) and PRV583 (open bars) were
used in a combined heparin elution/penetration assay on gC-3 (B) and
gC-583 (C) cells as described in Materials and Methods. The average
number of plaques on treated monolayers is expressed as a percentage of
the average number of plaques on control monolayers. Each bar represents
the mean of two independent experiments, and the error bars show the
standard errors.
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cells (Fig. 5); this value was similar to that shown in Fig.
1B. When cyto D was present, the wild-type penetration
level dropped to 34% at 1 h, a 40% reduction in efficiency.
Examination of the monolayers after the assay showed that
this reduction was not because of preferential loss of cyto D
treated cells during PBS washes. The same experiment was
performed on gC-9 cells infected with PRV583, except that
it was adapted to an infectious centers format. The penetra-
tion level dropped from 23% in the absence of cyto D to
15% in the presence of cyto D, a 35% reduction in effi-
ciency (Fig. 5). However, the low efficiency of PRV583
entry, even on gC-9 cells, under these conditions prevented
critical evaluation of the results.
It has been reported that PRV particles contain actin
(Wong and Chen, 1998). Therefore, in a control experiment,
wild-type PRV particles were incubated with 2.5 M cyto D
in medium at 37°C for 1 h prior to inoculation of untreated
PK15 cells; this treatment had a negligible effect on virus
penetration (data not shown).
In another control experiment, PK15 cells were pre-
treated and exposed to virus in the presence of 5 M
nocodazole, which leads to disassembly of microtubules.
After a 1 h inoculation period at 37°C, no detrimental effect
on the level of wild-type virus entry was observed, as the
average percentage of entry differed by only 8% on un-
treated cells versus nocodazole treated cells (data not
shown). Thus, the effect of cyto D treatment appeared to be
related specifically to disruption of actin filaments and not
to a general effect on cytoskeletal structure.
The actin cytoskeleton is involved in the binding of wild-
type virus to non-HS coreceptors
Does the loss of actin filaments affect virus progression
to non-HS coreceptors, or are other penetration events af-
fected subsequent to coreceptor binding? This question was
in part addressed by determining the percentage of bound
wild-type PFU that gained resistance to heparin elution in
Fig. 4. Immunofluorescence images of gC binding sites on PK15 cells. PK15 cells fixed with 2% paraformaldehyde (A–C) or left unfixed (D–F) were
incubated with soluble gC at 37°C for 30 min and fixed in 2% paraformaldehyde before staining. Actin filaments were stained with FITC-phalloidin. Soluble
gC was labeled with goat anti-gC polyclonal antibody bound by rhodamine-conjugated donkey anti-goat secondary antibody. Black and white images depict
gC (A and D) and actin filaments (B and E). Merged images of gC labeled in red and actin filaments in green are shown in panels C and F. All images were
captured at 126 magnification. Representative images were selected for presentation from multiple images of independent experiments. Merged images of
the same field were generated using Adobe Photoshop 4.0.
Fig. 5. Effect of cyto D on virus penetration. Standard penetration assays
were performed as described in Materials and Methods. When used, cyto
D was present during preincubation (30 min at 37°C) and penetration (1 h
at 37°C). Solid bars represent penetration values in the absence of cyto D,
while open bars represent penetration values in the presence of cyto D. The
y-axis represents the average number of plaques on monolayers treated
with citrate expressed as a percentage of the average number of plaques on
control monolayers. Each bar represents the mean of at least two indepen-
dent experiments and the error bars show the standard errors.
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the absence or presence of cyto D (see Materials and Meth-
ods). The results of two independent experiments are shown
in Table 1; the average results can be summarized as fol-
lows. In the absence of cyto D, 99% of wild-type virions
had acquired heparin resistance by 30 min, while only 69%
of the virions had bound a non-HS coreceptor in the pres-
ence of cyto D. Therefore, loss of actin filaments decreased
virus binding to non-HS coreceptors by 30% at 30 min. This
may explain, at least in part, the entry defect observed in the
presence of cyto D.
We also observed an increased eop of wild type on cells
exposed to cyto D. Independent experiments (Table 1)
showed an increased eop of about 30%. Since the effects of
cyto D are reversible and cyto D was only present prior to
and during inoculation in these experiments, it seems likely
that the increased eop reflected the alteration of an early
event in infection, possibly an increase in the levels or
availabilities of receptors.
Treatment with cyto D also affects steps subsequent to
binding of non-HS coreceptors
The potential sensitivity to cyto D treatment of PRV583
entry into gC-9 cells (Fig. 5) cannot be explained by a delay
in binding to a non-HS coreceptor because bound PRV583
particles bypass the HSPG receptors. This result suggested
that the actin cytoskeleton also impacts on virus entry in
steps following attachment. Therefore, we attempted to as-
say directly for the effect of cyto D on late entry events.
Monolayers were either left untreated or treated with cyto D
prior to inoculation with virus at 4°C for 2 h. The inocula on
cyto D-treated monolayers also contained cyto D. After the
inoculation period, a heparin wash was employed to ensure
that virtually all virions were bound to non-HS coreceptors.
Incubation was then continued for 1 h at 37°C, with cyto D
present in the medium of monolayers previously exposed to
drug. When compared to control infections, constant expo-
sure to cyto D prior to citrate treatment reduced wild-type
penetration on PK15 cells by 25% and PRV583 penetration
on gC-9 cells by 42% (Fig. 6). Thus, for both viruses,
penetration was significantly reduced or delayed by the
depolymerization of actin filaments. Because cyto D was
necessarily added prior to inoculation, we cannot rule out an
adverse effect on non-HS coreceptor activity. However, the
effect was reversible, because normal penetration was ob-
served if monolayers were exposed to cyto D before and
during inoculation, but not after the heparin wash step (data
not shown).
Discussion
We have confirmed and extended previous observations
that PRV gC null mutants are defective not only in virus
attachment but virus penetration as well (Flynn et al., 1993;
Mettenleiter, 1989). To our knowledge, our work with gC-9
cells is the first demonstration that a viral attachment protein
can complement an entry defect in trans. Clearly gC’s chief
role in PRV infection is to localize the virus to the cell
surface and facilitate the binding of a coreceptor. However,
our results showing that gC-9 cells can complement a pen-
etration, but not attachment, defect indicate that gC-HSPG
complexes can do more than simply provide a mechanism
for adhesion strengthening of the virus to the cell surface.
This idea was further supported by our observation that
even wild-type penetration was enhanced on gC-9 cells,
Table 1
Effect of cyto D treatment on wild type binding to non-HSPG receptors
Experiment 1 Experiment 2
Avg. no. of plaques per dish Avg. no. of plaques per dish
 heparin (eop)a  heparin % bound  heparin (eop)  heparin % bound
 cyto D 193 (100%) 193 100 278 (100%) 276 99
 cyto D 298 (154%) 197 66 321 (115%) 230 72
a Efficiency of plating was defined as 100% on monolayers not exposed to heparin or cyto D.
Fig. 6. Combined heparin elution/penetration profiles in the absence or
presence of cyto D. Assays were performed as described in Materials and
Methods. Solid bars represent penetration values in the absence of cyto D,
while open bars represent penetration values in the presence of cyto D.
When used, cyto D was present during preincubation (30 min at 37°C),
binding (2 h at 4°C), and penetration (1 h at 37°C). The y-axis represents
the average number of plaques on monolayers treated with citrate ex-
pressed as a percentage of the average number of plaques on control
monolayers. Each bar represents the mean of at least two independent
experiments, and the error bars show the standard errors.
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suggesting that the formation of gC-HSPG complexes prior
to virus attachment could predispose cells to rapid infection.
The efficient penetration of virions appeared to rely on
filamentous actin, as disruption of another cytoskeletal com-
ponent, microtubules, did not appear to affect the rate of
virus entry. Admittedly, we did not observe the abolishment
of entry that has been reported for certain retroviruses after
the treatment of cell monolayers with cyto D (Iyengar et al.,
1998; Kizhatil and Albritton, 1997). Still, we consistently
achieved a 35–40% reduction in PRV entry in the presence
of cyto D as measured by a standard penetration assay
conducted at 37°C for 1 h. Further analyses indicated that
both engagement of a non-HS coreceptor and entry subse-
quent to coreceptor binding benefited from an intact cy-
toskeleton. Our findings are consistent with previous work
describing an intermediate effect of cyto D on HSV-1 entry
into HEp-2 (Rosenthal et al., 1985). However, another
group reported that HSV-1 entry of Vero cells is unaffected
by cyto D treatment (Sodeik et al., 1997), and we have
found this also to be true for PRV entry of Vero cells (Rue
and Ryan, unpublished observations). Therefore, the re-
quirement of filamentous actin for efficient virus entry ap-
pears to be cell type or species specific.
When bound by ligands, HSPGs oligomerize and, in the
case of syndecans, associate with the actin cytoskeleton
through the binding of PDZ domain-containing proteins that
link to filamentous actin (Grootjans et al., 1997; Hsueh et
al., 1998). As a result, the HSPGs act as scaffolding to form
signaling complexes in which the signaling event is medi-
ated by other receptors (Rapraeger and Ott, 1998). In addi-
tion, syndecans may play an even more direct role in signal
transduction, as syndecan-4 is phosphorylated at a serine
residue conserved among all of the syndecans and synde-
can-3 associates with Src family kinases, again at a site
conserved in all syndecans (Horowitz and Simons, 1998;
Kinnunen et al., 1998).
Therefore, it is possible that gC-HSPG complexes pro-
mote a signaling event that facilitates virus entry. Such a
mechanism would be consistent with gC’s ability to act
either in cis or trans at the level of penetration. Recently,
Simmen et al. (2001) demonstrated that the binding of
human cytomegalovirus gB to an unidentified receptor re-
sulted in virtually the same pattern of gene expression in
fibroblasts as the addition of type I interferons. Thus, a
precedent exists for cell signaling that is mediated by a
single herpesvirus glycoprotein. But the gB-induced gene
expression occurred over an extended period of time, and
our results indicated that gC-HSPG interactions could re-
store wild-type virus entry to gC mutants in less than 60 min
while not resulting in a general increase in plating efficiency
on gC-9 cells. Thus, a specific role in the rate of virus
penetration, perhaps occurring too rapidly to be accounted
for by a signal transduction event, is suggested here. What,
then, could be an alternative explanation for how gC-HSPG
complexes facilitate PRV entry into PK15 cells?
We favor a model in which the scaffolding properties of
HSPG oligomers are usurped by the virus to increase the
propinquity of viral coreceptors. Others have previously
suggested that the multivalent nature of a herpesvirus en-
velope works in conjunction with an intact actin cytoskel-
eton to promote virus penetration (Rosenthal et al., 1985).
Our results indicate that gC plays a key role in the efficiency
of this process. Upon binding HSPGs, gC (either localized
in the virus envelope or residing in target cell membranes in
the case of gC-expressing cells) may lead to HSPG oli-
gomerization and promote their association with the actin
cytoskeleton. Using filamentous actin to restrict diffusion,
the gC-HSPG complex would stabilize an interaction with,
or perhaps even actively recruit, a non-HS coreceptor(s).
The stabilized complex would then promote rapid virus
entry. The nature of the proposed stabilized complex is not
clear. gC-HSPG complexes may alter the interaction of gD
with known coreceptors. Alternatively, the stabilized com-
plex may consist of additional, unidentified cellular compo-
nents that perhaps interact with some of the other viral
glycoproteins known to be required in virus entry. In the
absence of gC-HSPG interactions, the additional compo-
nents, whose existence has been postulated by others
(Karger et al., 1998), may not have the proper proximity to
efficiently interact with virions bound through gD alone.
This model, of course, does not rule out a concurrent signal
transduction event.
A few final points should be considered. We were unable
to complement the entry defect of gC mutants using a
soluble form of wild-type gC, suggesting that gC must be
anchored in a membrane to facilitate virus penetration (Rue
and Ryan, unpublished observations). When bound by
HSPGs, soluble and insoluble ligands lead to different cel-
lular consequences (Park et al., 2000). Soluble ligands such
as growth factors can use HSPGs as cofactors in regulating
signal transduction events through specific receptors. Other
soluble receptors are readily internalized after binding
HSPGs. Insoluble ligands immobilize HSPGs in the mem-
brane and promote the binding of proteoglycans to actin
filaments. This can subsequently lead to the formation of a
signaling complex. Because our soluble form of gC was
able to promote HSPG localization with or near the actin
cytoskeleton, the reason for the soluble form’s inability to
promote rapid virus penetration remains unclear. Finally,
our suggestion that stable complex formation is reliant upon
filamentous actin appears to be at odds with reports that
cytoplasmically-truncated forms of nectin-1 (HveC),
which are unable to associate with filamentous actin through
afadin, still mediate HSV entry (Cocchi et al., 1998;
Sakisaka et al., 2001). However, this is in fact consistent
with the intermediate reduction in virus entry observed for
cyto D treated cells. Moreover, it has been demonstrated
recently that PRV is not dependent on nectin-1 to infect
PK15 cells (Milne et al., 2001). Rather, an alternative co-
receptor must also exist in these cells. If the unidentified
coreceptor is not made in abundance in PK15 cells, then the
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proposed scaffolding properties of gC-HSPG complexes
may take on increased significance. This may at least par-
tially explain the effects of cyto D treatment reported here,
and may suggest that the reliance on filamentous actin for
PRV entry may vary from cell type to cell type, depending




PK15 (porcine kidney) cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 5%
fetal bovine serum and 100 units/ml of penicillin and 100
g/ml of streptomycin (DMEM/5%). Virus was propagated
in DMEM supplemented with 2% fetal bovine serum and
100 units/ml of penicillin and 100 g/ml of streptomycin
(DMEM/2%). For plaque formation, infected cell monolay-
ers were overlaid with DMEM/2% containing 1% methyl-
cellulose (methylcellulose medium). PRV523 and PRV583
are derivatives of PRV-Becker (PRV-Be), our wild-type
strain; all of these strains have been described previously
(Flynn et al., 1993; Flynn and Ryan, 1996).
To isolate cells expressing wild-type gC, a 2600 base
pair (bp) DraI-XbaI fragment from pGBe4.3 (Flynn et al.,
1993) was cloned into the EcoRV-XbaI site of pcDNA3
(Invitrogen Corp., Carlsbad, CA). The resulting plasmid
contained the entire coding region of gC flanked by approx-
imately 40 bp of PRV DNA upstream and 1100 bp down-
stream (to a naturally-occurring PstI site in the PRV ge-
nome). The gC gene was now under the control of the
cytomegalovirus immediate early promoter. This construct
was then transfected by the calcium phosphate method into
PK15 cells and grown in the presence of 1.0 mg/ml of G418
to select for transformants. Several individual colonies of
transformants were picked and maintained separately. gC-9,
the clone with the highest level of expression as determined
by indirect immunofluorescence microscopy with poly-
clonal goat anti-gC antibody 282 (Ryan et al., 1987), and
clone gC-3 were selected for use in these experiments.
Using a similar strategy, cells expressing the PRV583 allele
of gC were also obtained. All gC-expressing cells were
passaged in DMEM/5% with 750 g/ml of G418. Cells to
be used in experiments were seeded the previous day into
media without G418.
Attachment assay
Attachment assays were performed as previously de-
scribed, except that the assays were performed at 37°C
instead of 4°C (Flynn et al., 1993). Reported values are the
averages of at least two independent experiments.
Penetration assays
I. Standard penetration assays at 37°C. Duplicate sets of
three confluent cell monolayers in 60-mm dishes were in-
cubated at 37°C for 1 h with approximately 150 PFU of
virus diluted in DMEM/2%. The inocula were then removed
and one set of monolayers was treated with citrate buffer
(40 mM sodium citrate, 10 mM KCI, 135 mM NaCl [pH
3.0]) for 2 min. Treated monolayers were then washed twice
with PBS and overlaid with methylcellulose medium. The
untreated (control) monolayers were overlaid with methyl-
cellulose medium immediately after removal of inoculum.
The plaques were counted about 36 h later, and the effi-
ciency of penetration was calculated as a percentage of
control values. Reported values are the averages of at least
two independent experiments.
The effect of cyto D on penetration was measured by
pretreating both sets of three monolayers. A 10 mM stock of
cyto D (Sigma-Aldrich Co., St. Louis, MO) in dimethyl-
sulfoxide was added to cells in DMEM/2% to a final con-
centration of 2.5 M at 37°C for 30 min. Virus inocula
including cyto D were then incubated with cells for 1 h at
37°C. Afterwards, one set of monolayers received citrate
treatment and the other set did not. This was followed by the
addition of methylcellulose medium (lacking cyto D) to
promote plaque formation. The efficiency of penetration
was expressed as a percentage of control values and com-
pared to the penetration efficiency obtained on cells not
treated with cyto D. Reported values are the averages of at
least two independent experiments.
An identical protocol was followed for treatment of
PK15 cells with nocodazole except that a final concentration
of 5 M was used and pretreatment was for 1 h instead of
30 min. Under these conditions, microtubules were dis-
rupted as judged by diffuse staining of -tubulin during
immunofluorescence microscopy using mouse monoclonal
antibody TUB 2.1 (Sigma-Aldrich Co.). The results of two
independent experiments are reported.
II. Combined heparin elution/penetration assays. Dupli-
cate sets of three confluent cell monolayers (prechilled at
4°C for 30 min) were incubated at 4°C for 2 h with approx-
imately 150 PFU of virus diluted in ice-cold DMEM/2%.
Both sets of monolayers were then washed twice with ice-
cold DMEM/2% containing 5 g/ml of heparin (Sigma-
Aldrich Co.), followed by incubation at 37°C in DMEM/
2%. After 1 h, penetration was assayed by citrate treatment
as detailed above. Use of higher concentrations of heparin
did not alter the outcome of experiments.
For the time course experiment, infections were incu-
bated at 4°C and washed with medium containing heparin as
described above. At 30, 60, and 120 min after the addition
of warm medium, monolayers were treated with citrate
buffer and overlaid with methylcellulose medium. These
monolayers were then compared to infected control mono-
layers that were simply overlaid with methylcellulose me-
dium 120 min after the addition of warm medium.
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For combined heparin elution/penetration assays in the
presence of cyto D, both sets of three monolayers were
pretreated at 37°C with 2.5 M cyto D for 30 min. Mono-
layers were then prechilled to initiate the combined heparin
elution/penetration assay, and cyto D was maintained
throughout the experiment up to the point of methylcellu-
lose addition. The penetration efficiency was compared to
that obtained on cells not treated with cyto D. Reported
values are the averages of at least two independent experi-
ments.
Infectious centers assay
For all assays performed on gC-9 cells, infectious centers
assays were used. Duplicate sets of three confluent mono-
layers of gC-9 cells were infected with approximately 105
PFU of virus (multiplicity of infection 0.1). Otherwise,
assays were performed as described for measurements on
PK15 cells. After PBS washes or citrate treatments, cells
were trypsinized, and an empirically-determined amount of
cells in suspension was added to methylcellulose medium
and added to PK15 cell monolayers for plaque formation.
Efficiencies of attachment and penetration were then ex-
pressed as percentages of control values also obtained by
infectious centers assays.
Heparin elution assay
One set of duplicate pairs of PK15 cell monolayers was
pretreated with 2.5 M cyto D at 37°C for 30 min. About
150 PFU of virus diluted in DMEM/2% were then added to
all monolayers at 37°C for 30 min; the pretreated monolay-
ers received inocula containing 2.5 M cyto D. For each
pair, the inocula were removed and one monolayer was
washed with DMEM/2% and the other was washed with
DMEM/2% containing 5 g/ml of heparin. All monolayers
were then overlaid with methylcellulose medium (lacking
cyto D) for plaque formation. Plaques were counted after
36 h and values given are the number of PFU resistant to
heparin wash expressed as a percentage of total control PFU
resistant to DMEM/2% wash.
Immunofluorescence
PRV612 (Rue and Ryan, 2002) encodes a secreted hy-
brid protein composed of the wild-type gC ectodomain
fused to a modified cellulose binding domain (CBD) from
Cellulomonas fimi (Novagen, Inc., Madison, WI). The hy-
brid protein retains all conformation-dependent epitopes of
the wild-type species that we can measure. To prepare
soluble gC-CBD fusion proteins, PK15 cells on ten 100-mm
dishes were inoculated with PRV612 at a multiplicity of
infection of 10 for 1 h at 37°C. Inocula were then removed
and 4 ml of 37°C DMEM/2% were added to each dish.
Sixteen h postinfection, culture media were collected and
ultracentrifuged at 4°C for 1 h at 14,000 rpm in a Sorvall
TH641 rotor to pellet any virions. Supernatants were then
applied to an equilibrated cellulose (CBinD 300) column
(Novagen, Inc.) and washed with 800 mM NaCl, 20 mM
Tris pH 7.5. Fusion proteins were then eluted in 1 ml of
ethylene glycol, dialyzed against 10 mM ammonium bicar-
bonate, and lyophilized. The fusion proteins were resus-
pended in 100 l PBS containing 3% BSA. Typically, 2 l
of this preparation in 50 l of DMEM/2% were added for
30 min at 37°C to PK15 cells seeded on glass coverslips.
Cells were fixed with 2% paraformaldehyde in PBS for 10
min at room temperature and then rinsed three times with
PBS. For experiments on prefixed cells, cells on coverslips
were fixed for 10 min at room temperature with 2% para-
formaldehyde and rinsed three times with PBS before being
incubated with soluble gC-CBD. Bound gC-CBD was de-
tected with goat anti-gC polyclonal antibody 282 diluted
1:1000 in 0.5% Triton X-100, 3% BSA in PBS. After three
rinses with PBS, cells were incubated with Rhodamine
Red-X-conjugated donkey anti-goat secondary antibody
(Jackson Immunoresearch Laboratories, Inc., West Grove,
PA) and fluorescene isothiocyanate (FITC)-labeled phalloi-
din (Sigma-Aldrich Co.), each diluted 1:200 in 0.5% Triton
X-100, 3% BSA in PBS. Following a final three rinses in
PBS, coverslips were mounted with 80% glycerol on glass
slides and images were captured with a Zeiss Axiophot
digital UV microscope.
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